Startseite The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck

  • Ching-Chih Lee , Moon-Sing Lee , Hsu-Chueh Ho , Shih-Kai Hung , Ya-Ting Tung , Pesus Chou und Yu-Chieh Su
Veröffentlicht/Copyright: 11. September 2009
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: The aim of this study was to determine whether haptoglobin (Hp) genotypes are associated with prognosis in patients with squamous cell carcinoma of the head and neck (HNSCC).

Methods: We studied patients with HNSCC without distant metastasis at diagnosis. The Hp genotype of each patient was determined and the prognostic significance of the Hp genotype was further analyzed. Pearson's χ2-test or Fisher's exact test were used to analyze correlations between Hp genotype and clinical characteristics of HNSCC. Eighty patients with newly diagnosed HNSCC who were treated with curative modality were enrolled in this study. Kaplan-Meier plots and log-rank test were used to compare locoregional recurrence-free survival, distant-metastasis-free survival and overall survival of patients according to Hp genotype. Survival analysis was performed using Cox proportional hazard models.

Results: Eighty patients with newly diagnosed HNSCC were enrolled in this study. There was no significant difference in the distribution of Hp genotypes in HNSCC patients and healthy individuals (p=0.959). Matched-pair analysis showed that locoregional recurrence-free survival was poor (p=0.02) for HNSCC patients with Hp 2-2 or 2-0. There was no significant difference in distant metastasis-free survival and overall survival (p=0.422 and 0.509, respectively). Multivariate analysis showed that Hp 2-2 or 2-0 was associated with an increased risk of locoregional recurrence [Hazard ratio (HR) 5.9; 95% confidence interval (CI), 1.1–6.65; p=0.038]. The risk was still higher in patients with Hp 2-2 or 2-0 after further adjusting for age and treatment modality (HR 7.6; 95% CI, 1.2–46; p=0.028) in locoregional recurrence-free survival.

Conclusions: The present data show that the Hp genotype is closely related to recurrence rate in patients with HNSCC. Patients with Hp 2-2 or 2-0 have greater locoregional recurrence and significantly increased HRs in multivariate analysis. The Hp genotype may be a prognostic factor in patients with HNSCC.

Clin Chem Lab Med 2009;47:1277–83.


Corresponding author: Yu-Chieh Su, Division of Hematology-Oncology, Department of Internal Medicine, Buddhist Tzu Chi Dalin General Hospital, No. 2 Min-Sheng Road, Dalin, Chiayi 622, Taiwan Phone: +886 5 2854000 Ext. 5231, Fax: +886 5 2648006,

Received: 2009-5-11
Accepted: 2009-7-7
Published Online: 2009-09-11
Published in Print: 2009-10-01

©2009 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorial
  2. Cardiac troponins: what we knew, what we know – where are we now?
  3. Review
  4. Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?
  5. Opinion Papers
  6. A critical appraisal of experimental factors influencing the definition of the 99th percentile limit for cardiac troponins
  7. Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications
  8. The future of hospital laboratories. Position statement from the Royal Belgian Society of Clinical Chemistry (RBSCC)
  9. Point
  10. Quantity quotient reporting. A proposal for a standardized presentation of laboratory results
  11. Counterpoint
  12. Quantity quotient reporting. Counterpoint
  13. Perspectives
  14. Increasing laboratory medicine activities in China: research and publications
  15. Contributions in Biochemistry and Molecular Biology from China and other top-ranking countries: a 10-year survey of the literature
  16. Genetics and Molecular Diagnostics
  17. SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells
  18. Polymorphisms of the β1-adrenergic receptor gene are associated with essential hypertension in Chinese
  19. Egyptian glycogen storage disease type III – identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId
  20. Novel rare alleles of ABCA1 are exclusively associated with extreme high-density lipoprotein-cholesterol levels among the Han Chinese
  21. –308G>A and –1031T>C tumor necrosis factor gene polymorphisms in Tunisian patients with coronary artery disease
  22. General Clinical Chemistry and Laboratory Medicine
  23. Error tracking in a clinical biochemistry laboratory
  24. HbA1c measurements from dried blood spots: validation and patient satisfaction
  25. Pre-transplant serum concentrations of anti-endothelial cell antibody in panel reactive antibody negative renal recipients and its impact on acute rejection
  26. Cancer Diagnostics
  27. Detection of Meningeosis neoplastica by real-time quantitation of telomerase activity
  28. The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck
  29. Evaluation of a new method for the diagnosis of alterations of Lens culinaris agglutinin binding of thyroglobulin molecules in thyroid carcinoma
  30. The soluble transferrin receptor (TfR)-F-Index is not applicable as a test for iron status in patients with chronic lymphocytic leukemia
  31. Impact of calibration fitting models on the clinical value of chromogranin A
  32. Letters to the Editor
  33. Clinical value of a competitive NT-proBNP enzyme immunoassay compared to the Roche NT-proBNP platform
  34. Should gender-related reference values be used for total bilirubin?
  35. A novel nonsense mutation in the albumin gene (c.1275 C>A) causing analbuminemia in a Tunisian boy
  36. Abstracts
  37. 41st National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, 2nd Joint National Event SIBioC-SIMeL
Heruntergeladen am 6.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.275/pdf
Button zum nach oben scrollen